Kronos Worldwide, Inc. filings document operating results, governance, capital structure and material events for a titanium dioxide producer with common stock listed on the New York Stock Exchange under KRO. Recent Form 8-K reports furnish earnings releases, dividend announcements, executive succession disclosures and Regulation FD information.
The filing record also includes definitive proxy materials for annual meeting matters and board governance, as well as debt financing disclosures involving Kronos International, Inc., a wholly owned subsidiary, and senior secured notes due 2029. These documents describe registered securities, subsidiary obligations, indenture supplements, material agreements and executive compensation matters.
Kronos Worldwide, Inc. reported third-quarter 2026 net income of $34.8 million, or $0.30 per share, compared with a $37.0 million net loss, or a $0.32 per-share loss, a year earlier. Net sales were $541.1 million, up 18% from $456.9 million. For the first nine months, net income was $45.2 million versus a $28.1 million loss, while net sales rose 12% to $1,609.0 million from $1,441.1 million. The company attributed higher income mainly to higher sales and production volumes, lower raw-material costs and lower production costs.
Third-quarter TiO2 segment profit was $61.0 million versus a $15.3 million loss, and EBITDA was $72.7 million versus $0.6 million; both are company-reported non-GAAP measures. Average TiO2 selling prices were 5% higher year over year in the quarter, but 1% lower for the nine-month period. Kronos expects normal seasonal trends to soften fourth-quarter demand and expects lower production volumes due to recurring maintenance at several facilities; inventory is expected to remain below historical levels.
Kronos Worldwide (KRO) reported third-quarter 2026 net sales of $541.1 million, up 18% from $456.9 million, and net income of $34.8 million, versus a $37.0 million loss a year earlier. Gross margin was $127.4 million versus $47.0 million. The company cited higher sales and production volumes, lower feedstock and production costs, and higher average TiO2 selling prices; net income included a $12.1 million non-cash deferred tax benefit.
Nine-month net sales were $1,609.0 million, up 12%, and net income was $45.2 million versus a $28.1 million loss. Operating activities provided $54.9 million of cash, compared with $89.6 million used a year earlier. At September 30, 2026, total debt was $539.9 million, cash, cash equivalents and restricted cash totaled $40.1 million, and Global Revolver availability was approximately $254 million.
Management expects full-year 2026 net sales and sales volumes to exceed 2025 levels, with gross and operating income margins expected to improve.
Kronos Worldwide, Inc. (KRO) announced that its board declared a regular quarterly dividend of $0.05 per share on its common stock. The dividend is payable on December 10, 2026, to stockholders of record at the close of business on November 19, 2026.
Kronos Worldwide, Inc. reported a turnaround for the quarter and six months ended June 30, 2026. Second-quarter net income was $15.2 million, or $0.13 per share, compared with a net loss of $9.2 million, or $0.08 per share, a year earlier. Net sales rose to $558.1 million from $494.4 million, while TiO2 segment profit increased to $41.0 million from $10.9 million and EBITDA rose to $52.9 million from $22.2 million. For the first six months of 2026, net income was $10.4 million, or $0.09 per share, versus $8.9 million, or $0.08 per share, in 2025.
Management attributes the improvement mainly to higher TiO2 sales volumes, market share gains and lower production and raw material costs following cost reduction initiatives implemented in the fourth quarter of 2025, partly offset by lower average TiO2 selling prices and weaker complementary businesses. Currency fluctuations, primarily the euro, reduced segment profit by approximately $12 million in the second quarter of 2026 and approximately $18 million in the first six months of 2026. Results also include $2.0 million of income tax expense for an uncertain German tax position. The board declared a regular quarterly dividend of $0.05 per share, payable September 17, 2026 to stockholders of record on September 3, 2026.
Kronos Worldwide, Inc., a global titanium dioxide producer, reported stronger results for 2026. For the three months ended June 30, 2026, net sales were $558.1 million and net income was $15.2 million, or $0.13 per share, compared with a loss in the prior-year quarter. Gross margin improved to 18% of net sales as higher TiO₂ sales volumes, lower raw material and production costs, and reduced unabsorbed fixed costs more than offset lower average selling prices and currency headwinds.
For the first six months of 2026, net sales were $1,067.9 million and net income was $10.4 million, or $0.09 per share. TiO₂ sales volumes rose 10% year over year while average selling prices declined 4%. Cash from operations turned slightly positive at $2.0 million, helped by a significant inventory drawdown that reduced days sales in inventory to 35 days. At June 30, 2026, the company held $34.5 million in cash, cash equivalents and restricted cash, total debt of $569.6 million (including $487.7 million of 9.50% Senior Secured Notes and $28.2 million drawn on its Global Revolver), with about $261 million of revolver availability. Management continues quarterly dividends of $0.05 per share and expects 2026 net sales and margins to exceed 2025, supported by higher volumes, ongoing cost reduction benefits from 2025 restructuring, and further pricing initiatives, while demand in North America remains below historical levels.
Kronos Worldwide Inc. director Kevin B. Kramer reported buying 14,601 shares of the company’s common stock in open-market transactions on May 18, 2026. The purchases were made at prices between $6.70 and $6.77 per share. Following these trades, he directly owns about 44,411 shares.
CHRISTIAN BRIAN W. reported acquisition or exercise transactions in this Form 4 filing.
Kronos Worldwide President and CEO Brian W. Christian received a grant of 5,550 shares of common stock at $7.22 per share. The shares were issued for no cash consideration under the 2012 Director Stock Plan and bring his directly held position to 5,550 shares.
Simmons Michael Shawn reported acquisition or exercise transactions in this Form 4 filing.
KRONOS WORLDWIDE INC director and vice chairman Michael Shawn Simmons received 5,550 shares of common stock as a grant under the company’s 2012 Director Stock Plan. The shares were valued at $7.22 per share for reporting purposes and were issued for no cash consideration.
Following this award, Simmons directly holds 10,550 shares of Kronos Worldwide common stock. This transaction reflects equity-based director compensation rather than an open-market purchase or sale.
MOORE CECIL H JR reported acquisition or exercise transactions in this Form 4 filing.
Kronos Worldwide, Inc. director Cecil H. Moore Jr. received an equity award of 5,550 shares of common stock on May 13, 2026. The shares were issued for no cash consideration under the Kronos Worldwide, Inc. 2012 Director Stock Plan at a reported value of $7.22 per share. Following this grant, his direct holdings increased to 36,324 common shares.
Mendes Meredith W. reported acquisition or exercise transactions in this Form 4 filing.
KRONOS WORLDWIDE INC director Meredith W. Mendes reported receiving a grant of 5,550 shares of common stock on May 13, 2026. The shares were issued for no cash consideration under the Kronos Worldwide, Inc. 2012 Director Stock Plan, meaning this was a stock-based compensation award rather than an open-market purchase. After this grant, Mendes directly holds 19,300 shares of Kronos Worldwide common stock.